Typical reservoir hosts of Leptospira.
Abstract
Leptospirosis is a communicable disease at farms that results in abortion and pathological changes in animals and human respectively. Disease is majorly spreading through indirect contact with contaminated urine material. The causative agent belongs to Leptospira genus having 21 species, 25 serogroups, and 250 serovars. The prevalence noted at world level is counted to be 41.39% with 30.11% in Asia, 25.62% in Africa, and 46.42% in South Africa. The virulence is attributed to Loa22 protein which is the first protein identified as essential virulence factor. Pathogenesis involves vasculitis following which are direct cytotoxicity and immunological injury resulting in renal failure. Direct examination, PCR, isothermal methods, microscopic agglutination test (MAT) and IgM enzyme-linked immunosorbent assay (ELISA) are diagnostic approaches for leptospirosis. The MAT is a gold standard test for leptospirosis identification. Doxycycline and azithromycin were used as drugs against leptospirosis in mild and severe cases of leptospirosis. Further studies are needed regarding identification, treatment, and effective vaccination.
Keywords
- leptospirosis
- Leptospira
- disease outbreaks
- leptospirosis vaccine
- Leptospira tests
- epidemiology
- prevalence
1. Introduction
Leptospirosis is a worldwide but more neglected zoonotic disease that usually affects humans and animals around the world [1, 2, 3] with case records 350,000 annually [4]. Death occurs from 10 to 50% in severe infection cases [5]. Pathogenic
2. Etiology
Leptospirosis is a prominent communicable disease caused by spirochete bacteria. The bacterial species belong to genus

Figure 1.
Main characteristics of pathogenic and trophic genome
2.1 Prevalence of leptospirosis
Worldwide, the prevalence of animal leptospirosis is reported between 2 and 46% depending upon animal species [12]. More than 15 serogroups of
Reservoir host | Serovar | Reference |
---|---|---|
Pigs | Pomona, Tarassovi | [8] |
Cattle | Hardjo, Pomona | |
Horse | Bratislava | |
Dog | Canicola | |
Sheep | Hardjo | |
Rats | Icterohaemorrhagiae, Copenhageni | |
Bats | Cynopteri, Wolffi |
Table 1.
Country | Year | Diagnostic methods | Specie | Prevalence% | Reference |
---|---|---|---|---|---|
India | 1983 2011 | — MAT | Cattle — | 68 87 | [35] [36] |
Malaysia | 1987 | MAT | Cattle Buffalo | 40.5 31 | [37] |
Sri Lanka | 2011 2014 | MAT Nested PCR | Cattle Cattle | 20.31 12.2 | [38] [6] |
Iran | 2011 | MAT | Cattle | 19.10 | [39] |
Pakistan | 2018 | Indirect ELISA | Cattle Buffalo | 25.52 20.72 | [40] |
Bangladesh | 2015 | ELISA | Cattle | 47.27 | [41] |
Table 2.
Prevalence of bovine leptospirosis in different countries of Asia.
3. Pathogenesis
Leptospirosis is termed as “storm of abortion” and is farm economy jeopardizing malaise [42].
3.1 Known virulence factors
The emergence of the mutagenesis system revealed a small number of
4. Transmission
Transmission of

Figure 2.
Mechanism of
5. Diagnosis
Infection occurred by pathogenic leptospires is divided into two stages, first stage is acute stage or septicaemia (because septicaemia is in this stage), which lasts from 7 to 10 days with headache and myalgia. The second stage is immune stage which is after first week of infection and lasts 4–30 days [34]. During first stage, leptospires are present in blood and can say bacterial count is high in the blood, while when second stage starts, then the level of antibodies IgM and IgG start to increase and this increase in antibodies titer is correlated to elimination of leptospires from blood.
5.1 Current tools and emerging technologies for diagnosis of Leptospira
Different tools are being developed for the study of virulence factors, pathogenicity, and basic cell biology of organisms [52]. These are essential for proper treatment and reduction of the severity of the disease. During acute infection, nonspecific symptoms of leptospires mimic the febrile condition, which are essential for proper treatment and reduce the severity of the disease. Therefore, the diagnosis of leptospirosis is highly dependent on the particular laboratory tests [13]. Serology is the dominant one in diagnosis, while the micro-aggregation test (MAT) is the standard serological reference method. MAT is a sensitive test due to the antigenic heterogeneity of
5.1.1 Direct examination
This method is cheap, but for direct examination, dark field microscope is required [54]. Theoretically, leptospires may be diagnosed by direct examination of blood during first week after onset of symptoms. Leptospires are 6–20 μm long and their diameter is 0.15 μm. Because of their size, dark field microscopy is required; 10−2–10−6 leptospires/mL of blood may be observed during the acute stage of leptospirosis [55].
5.1.2 Gene amplification
5.1.2.1 PCR
The use of PCR is increasing in recent years and it has replaced the serological methods in endemic areas, because it is more sensitive and has capacity to give early diagnosis. Real-time PCR is faster than regular PCR [56]. The threshold level in the urine or blood is 10–100 leptospires/mL (Figures 3 and 4) [50, 57].

Figure 3.
Specificity of different diagnostic tests during acute phase of leptospirosis [

Figure 4.
Sensitivity of different diagnostic tests during acute phase of leptospirosis [
5.1.2.2 Isothermal methods
In recent years, many isothermal amplification techniques are developed like isothermal technique [59]. This technique can be used as alternative to the PCR. There is no need for constant maintenance of temperature at 60–65°C and no thermal recycler is required; so, these things make it best for developing countries. For this, an effective and specific amplification is performed by DNA polymerase and six primers in 1 hour under isothermal conditions. Now the amplified DNA can be easily detected by eye observation of fluorescence without using gel electrophoresis [60]. Loop-mediated isothermal amplification (LAMP) methods are recently developed for the quick diagnosis of pathogenic leptospires, and lipL41 and rrs are the genes targeted by LAMP. The specificity of these methods is weak because these can detect the threshold between 2 and 100 leptospires/reactive mixture [61].
5.1.3 Serological tests
5.1.3.1 The microscopic agglutination test (MAT)
This microscopic agglutination test is developed in Pasteur Institute. Dark field microscopy is required to see agglutination of live leptospires cultures with patient’s serum. This is the gold standard test for leptospirosis. It determines the anti-
5.1.3.2 IgM enzyme-linked immunosorbent assay (ELISA)
Normal ELISA is commonly used to diagnose leptospirosis. Enzyme immunoassay of leptospirosis can be performed using a commercially available kit or antigen obtained internally. Which is commonly used to detect IgM, and sometimes to detect IgG antibodies against leptospiral antigens. The presence of IgM antibodies indicates current or recent leptospirosis. The commercially available
6. Necropsy findings
Cows with acute leptospirosis are characterized by anemia, jaundice, hemoglobinuria, and lower lobe hemorrhage. An ulcer and bleeding may be present on the mucous membrane of the peritoneum. Pulmonary edema and emphysema are also common in cattle. Histologically, there is a progressive and diffuse interstitial nephritis and liver necrosis in the centre of the lobules. Sometimes the vascular lesions of the meninges are transferred to chronic infections.
Samples for confirmation of diagnosis are kidney, liver and placenta. Histology of kidney, liver, brain, heart, lungs and placenta can be performed. While for serological analysis heart blood serum or pericardial fluid from foetus can also be obtained.
The zoonotic potential of this organism should keep in mind during handling of carcasses and submitting specimens.
7. Treatment
Treatment is based on severity of illness being presented by animal which in most of the cases is mild and self-limiting requiring no care. Other considerations, while treatment is considered, include differential diagnosis, cost, and availability of drugs. Treatment obtained based on in-vitro studies presented doxycycline, ampicillin, azithromycin or amoxicillin [64]. The double-blind randomized trials conducted on 29 patients produced promising results by reducing symptoms of malaise in 2 days preventing leptospiremia. The treatment, however, was not conclusive prevention from progression to severity [65]. Doxycycline or azithromycin is the drug of choice in endemic areas while contraindicated in pregnancy [64]. Sever cases are responsive to penicillin G sodium in studies conducted before 90s. The emerging resistance has narrowed spectrum of antibiotic use against infections [66]. Open randomized trial conducted with experiment involving 256 patients proved nonsignificant difference among penicillin G, cefotaxime, and doxycycline antibiotics [67]. Some of meta-analysis studies have reported nonsignificant difference between penicillin G and placebo on mortality [68]. Mortality is reported to increase up to 70% with pulmonary involvement which is due to immune-mediated inflammatory response. The therapeutic indicated for this complication is steroidal drugs. Early steroid administration was found responsive but methodologically flawed in various studies. Desmopressin was evaluated in various randomized studies as adjunct therapy with nonsignificant mortality benefits [69]. Therapy is considered beneficial with doxycycline or azithromycin along with steroid administration in mild and severe cases. Variations in studies are reported with nonsignificant benefits to mortality reduction.
7.1 Blood transfusion
Leptospirosis is a zoonosis with worldwide distribution. It is more prevalent in the developing countries. Hemorrhagic manifestations constitute the common clinical feature in leptospirosis [70]. In cattle, acute hemolytic syndrome of leptospirosis has been reported characterized by fever, icterus, anemia, and hemoglobinuria [71]. Without effective treatment, hemolytic syndrome in cattle may result in death. A high mortality rate of severe disease was determined to be associated with certain serotypes of
7.2 Vaccination
The optimal control regime for leptospirosis is to prevent clinical disease and exfoliation in the urine in animals exposed to different serotypes of
8. Conclusion
Leptospirosis is a major zoonotic disease resulting in high mortality in humans and animals. The disease is diagnosed clinically by fever, headache, vomiting, abdominal pain, and arthralgia. Leptospirosis is caused by more than 250 serovars, while pomona and grippotyphosa being the most prevalent serovars among them. However, among cattle, serovar Hardjo is the most important in causation of disease. Among the Asian countries, the highest prevalence of leptospirosis was found in India. Leptospirosis is mainly transmitted by direct contact with infected urine, and bacteria are mainly entered through ruptured skin. In house IgM ELISA is highly specific technique for
References
- 1.
Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, et al. Global morbidity and mortality of leptospirosis: A systematic review. PLoS Neglected Tropical Diseases. 2015; 9 (9):e0003898 - 2.
Lambert A, Takahashi N, Charon N, Picardeau M. Chemotactic behavior of pathogenic and non-pathogenic Leptospira species. Applied and Environmental Microbiology. 2012; 78 (23):8467-8469 - 3.
Brenner DJ, Kaufmann AF, Sulzer KR, Steigerwalt AG, Rogers FC, Weyant RS. Further determination of DNA relatedness between serogroups and serovars in the family Leptospiraceae with a proposal for Leptospira alexanderi sp. nov. and four new Leptospira genomospecies. International Journal of Systematic and Evolutionary Microbiology. 1999; 49 (2):839-858 - 4.
Terpstra W. Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control. World Health Organization; 2003 - 5.
Marchiori E, Lourenço S, Setúbal S, Zanetti G, Gasparetto TD, Hochhegger B. Clinical and imaging manifestations of hemorrhagic pulmonary leptospirosis: A state-of-the-art review. Lung. 2011; 189 (1):1-9 - 6.
Gamage CD, Koizumi N, Perera AC, Muto M, Nwafor-Okoli C, Ranasinghe S, et al. Carrier status of leptospirosis among cattle in Sri Lanka: A zoonotic threat to public health. Transboundary and Emerging Diseases. 2014; 61 (1):91-96 - 7.
Athanazio DA, Silva EF, Santos CS, Rocha GM, Vannier-Santos MA, McBride AJ, et al. Rattus norvegicus as a model for persistent renal colonization by pathogenic Leptospira interrogans. Acta Tropica. 2008; 105 (2):176-180 - 8.
Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, et al. Leptospirosis: A zoonotic disease of global importance. The Lancet Infectious Diseases. 2003; 3 (12):757-771 - 9.
Sejvar J, Bancroft E, Winthrop K, Bettinger J, Bajani M, Bragg S, et al. Leptospirosis in “eco-challenge” athletes, Malaysian Borneo, 2000. Emerging Infectious Diseases. 2003; 9 (6):702 - 10.
Tique V, Mattar S, Miranda J, Oviedo M, Noda A, Montes E, Rodriguez V. Clinical and Epidemiological Status of Leptospirosis in a Tropical Caribbean Area of Colombia. BioMed research international. 2018; 2018 - 11.
Lau CL, Smythe LD, Craig SB, Weinstein P. Climate change, flooding, urbanisation and leptospirosis: Fuelling the fire? Transactions of the Royal Society of Tropical Medicine and Hygiene. 2010; 104 (10):631-638 - 12.
Ricaldi JN, Vinetz JM. Leptospirosis in the tropics and in travelers. Current Infectious Disease Reports. 2006; 8 (1):51-58 - 13.
Schreier S, Doungchawee G, Chadsuthi S, Triampo D, Triampo W. Leptospirosis: Current situation and trends of specific laboratory tests. Expert Review of Clinical Immunology. 2013; 9 (3):263-280 - 14.
Hartskeerl R, Collares-Pereira M, Ellis W. Emergence, control and re-emerging leptospirosis: Dynamics of infection in the changing world. Clinical Microbiology and Infection. 2011; 17 (4):494-501 - 15.
Perolat P, Chappel R, Adler B, Baranton G, Bulach D, Billinghurst M, et al. Leptospira fainei sp. nov., isolated from pigs in Australia. International Journal of Systematic and Evolutionary Microbiology. 1998; 48 (3):851-858 - 16.
Ren S-X, Fu G, Jiang X-G, Zeng R, Miao Y-G, Xu H, et al. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature. 2003; 422 (6934):888 - 17.
de la Peña-Moctezuma A, Bulach DM, Kalambaheti T, Adler B. Comparative analysis of the LPS biosynthetic loci of the genetic subtypes of serovar Hardjo: Leptospira interrogans subtype Hardjoprajitno and Leptospira borgpetersenii subtype Hardjobovis. FEMS Microbiology Letters. 1999; 177 (2):319-326 - 18.
Budihal SV, Perwez K. Leptospirosis diagnosis: Competancy of various laboratory tests. Journal of Clinical and Diagnostic Research: JCDR. 2014; 8 (1):199 - 19.
Haake DA, Levett PN. Leptospirosis in humans. Current Topics in Microbiology and Immunology. 2015; 387 :65-97 - 20.
Adler B, de la Peña Moctezuma A. Leptospira and leptospirosis. Veterinary Microbiology. 2010; 140 (3-4):287-296 - 21.
Guitian F, Garcı́a-Peña F, Oliveira J, Sanjuan M, Yus E. Serological study of the frequency of leptospiral infections among dairy cows in farms with suboptimal reproductive efficiency in Galicia, Spain. Veterinary Microbiology. 2001; 80 (3):275-284 - 22.
Ko AI, Goarant C, Picardeau M. Leptospira: The dawn of the molecular genetics era for an emerging zoonotic pathogen. Nature Reviews Microbiology. 2009; 7 (10):736 - 23.
Matsui M, Rouleau V, Bruyère-Ostells L, Goarant C. Gene expression profiles of immune mediators and histopathological findings in animal models of leptospirosis: Comparison between susceptible hamsters and resistant mice. Infection and Immunity. 2011; 79 (11):4480-4492 - 24.
Barbosa AS, Abreu PA, Vasconcellos SA, Morais ZM, Gonçales AP, Silva AS, et al. Immune evasion of leptospira species by acquisition of human complement regulator C4BP. Infection and Immunity. 2009; 77 (3):1137-1143 - 25.
Wolff DG, Castiblanco-Valencia MM, Abe CM, Monaris D, Morais ZM, Souza GO, et al. Interaction of leptospira elongation factor Tu with plasminogen and complement factor H: A metabolic leptospiral protein with moonlighting activities. PLoS One. 2013; 8 (11):e81818 - 26.
Fraga TR, Courrol DS, Castiblanco-Valencia MM, Hirata IY, Vasconcellos SA, Juliano L, et al. Immune evasion by pathogenic leptospira strains: The secretion of proteases that directly cleave complement proteins. The Journal of Infectious Diseases. 2013; 209 (6):876-886 - 27.
Adler B, Lo M, Seemann T, Murray GL. Pathogenesis of leptospirosis: The influence of genomics. Veterinary Microbiology. 2011; 153 (1-2):73-81 - 28.
Murray GL, Srikram A, Henry R, Puapairoj A, Sermswan RW, Adler B. Leptospira interrogans requires heme oxygenase for disease pathogenesis. Microbes and Infection. 2009; 11 (2):311-314 - 29.
Liao S, Sun A, Ojcius DM, Wu S, Zhao J, Yan J. Inactivation of the fliY gene encoding a flagellar motor switch protein attenuates mobility and virulence of leptospira interrogans strain Lai. BMC Microbiology. 2009; 9 (1):253 - 30.
Eshghi A, Becam J, Lambert A, Sismeiro O, Dillies MA, Jagla B, et al. A putative regulatory genetic locus modulates virulence in the pathogen Leptospira interrogans. Infection and Immunity. 2014; 82 (6):2542-2552 - 31.
Lee SH, Kim S, Park SC, Kim MJ. Cytotoxic activities of Leptospira interrogans hemolysin SphH as a pore-forming protein on mammalian cells. Infection and Immunity. 2002; 70 (1):315-322 - 32.
Markey B, Leonard F, Archambault M, Cullinane A, Maguire D. Clinical Veterinary Microbiology E-Book. Elsevier Health Sciences; 2013 - 33.
Boonsilp S, Thaipadungpanit J, Amornchai P, Wuthiekanun V, Bailey MS, Holden MT, et al. A single multilocus sequence typing (MLST) scheme for seven pathogenic Leptospira species. PLoS Neglected Tropical Diseases. 2013; 7 (1):e1954 - 34.
Picardeau M. Diagnosis and epidemiology of leptospirosis. Médecine et Maladies Infectieuses. 2013; 43 (1):1-9 - 35.
Ratnam S, Sundararaj T, Subramanian S. Serological evidence of leptospirosis in a human population following an outbreak of the disease in cattle. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1983; 77 (1):94-98 - 36.
Natarajaseenivasan K, Vedhagiri K, Sivabalan V, Prabagaran SG, Sukumar S, Artiushin SC, et al. Seroprevalence of Leptospira borgpetersenii serovar javanica infection among dairy cattle, rats and humans in the Cauvery river valley of southern India. Southeast Asian Journal of Tropical Medicine and Public Health. 2011; 42 (3):679 - 37.
Bahaman A, Ibrahim A, Adam H. Serological prevalence of leptospiral infection in domestic animals in West Malaysia. Epidemiology and Infection. 1987; 99 (2):379-392 - 38.
Gamage CD, Koizumi N, Muto M, Nwafor-Okoli C, Kurukurusuriya S, Rajapakse JR, et al. Prevalence and carrier status of leptospirosis in smallholder dairy cattle and peridomestic rodents in Kandy, Sri Lanka. Vector Borne and Zoonotic Diseases. 2011; 11 (8):1041-1047 - 39.
Tabatabaeizadeh E, Tabar GH, Farzaneh N, Seifi HA. Prevalence of Leptospira hardjo antibody in bulk tank milk in some dairy herds in Mashhad suburb. African Journal of Microbiology Research. 2011; 5 (14):1768-1772 - 40.
Ijaz M, Farooqi SH, Aqib AI, Bakht P, Ali A, Ghaffar A, et al. Sero-epidemiology of bovine leptospirosis and associated risk factors in a flood affected zone of Pakistan. Pakistan Veterinary Journal. 2018; 38 (2):179-183 - 41.
Parvez M, Prodhan M, Rahman M, Faruque M. Seroprevalence and associated risk factors of Leptospira interrogans serovar Hardjo in dairy cattle of Chittagong, Banladesh. Pakistan Veterinary Journal. 2015; 35 (3):350-354 - 42.
Ellis WA. Animal leptospirosis. In: Leptospira and leptospirosis. Berlin, Heidelberg: Springer; 2015. pp. 99-137 - 43.
Zuerner RL. Host response to Leptospira infection. In: Leptospira and Leptospirosis. Springer; 2015. pp. 223-250 - 44.
Stevenson B, Choy HA, Pinne M, Rotondi ML, Miller MC, DeMoll E, et al. Leptospira interrogans endostatin-like outer membrane proteins bind host fibronectin, laminin and regulators of complement. PLoS One. 2007; 2 (11):e1188 - 45.
Verma A, Hellwage J, Artiushin S, Zipfel PF, Kraiczy P, Timoney JF, et al. LfhA, a novel factor H-binding protein of Leptospira interrogans. Infection and Immunity. 2006; 74 (5):2659-2666 - 46.
Souza NM, Vieira ML, Alves IJ, de Morais ZM, Vasconcellos SA, Nascimento AL. Lsa30, a novel adhesin of Leptospira interrogans binds human plasminogen and the complement regulator C4bp. Microbial Pathogenesis. 2012; 53 (3-4):125-134 - 47.
Croda J, Figueira CP, Wunder EA, Santos CS, Reis MG, Ko AI, et al. Targeted mutagenesis in pathogenic Leptospira species: Disruption of the LigB gene does not affect virulence in animal models of leptospirosis. Infection and Immunity. 2008; 76 (12):5826-5833 - 48.
Verma A, Stevenson B, Adler B. Leptospirosis in horses. Veterinary Microbiology. 2013; 167 (1-2):61-66 - 49.
Boonsilp S, Thaipadungpanit J, Amornchai P, Wuthiekanun V, Bailey M. A single multilocus sequence typing (MLST) scheme for seven. 2013 - 50.
Smythe LD, Smith IL, Smith GA, Dohnt MF, Symonds ML, Barnett LJ, et al. A quantitative PCR (TaqMan) assay for pathogenic Leptospira spp. BMC Infectious Diseases. 2002;2 (1):13 - 51.
Bourhy P, Bremont S, Zinini F, Giry C, Picardeau M. Comparison of real-time PCR assays for the detection of pathogenic Leptospira spp. in blood and identification of variations in target sequences. Journal of Clinical Microbiology. 2011;49 (6):2154-2160 - 52.
Saint Girons I, Bourhy P, Ottone C, Picardeau M, Yelton D, Hendrix RW, et al. The LE1 bacteriophage replicates as a plasmid within Leptospira biflexa : Construction of anL. biflexa -Escherichia coli shuttle vector. Journal of Bacteriology. 2000;182 (20):5700-5705 - 53.
Picardeau M, Bertherat E, Jancloes M, Skouloudis AN, Durski K, Hartskeerl RA. Rapid tests for diagnosis of leptospirosis: Current tools and emerging technologies. Diagnostic Microbiology and Infectious Disease. 2014; 78 (1):1-8 - 54.
Vijayachari P, Sugunan A, Umapathi T, Sehgal S. Evaluation of darkground microscopy as a rapid diagnosis procedure in leptospirosis. Indian Journal of Medical Research. 2001; 114 :54 - 55.
Agampodi SB, Matthias MA, Moreno AC, Vinetz JM. Utility of quantitative polymerase chain reaction in leptospirosis diagnosis: Association of level of leptospiremia and clinical manifestations in Sri Lanka. Clinical Infectious Diseases. 2012; 54 (9):1249-1255 - 56.
Ahmed A, Engelberts MF, Boer KR, Ahmed N, Hartskeerl RA. Development and validation of a real-time PCR for detection of pathogenic Leptospira species in clinical materials. PLoS One. 2009;4 (9):e7093 - 57.
Stoddard RA, Gee JE, Wilkins PP, McCaustland K, Hoffmaster AR. Detection of pathogenic Leptospira spp. through TaqMan polymerase chain reaction targeting the LipL32 gene. Diagnostic Microbiology and Infectious Disease. 2009;64 (3):247-255 - 58.
Hashimoto VY, Dias JA, Spohr KA, Silva MC, Andrade MG, Müller EE, et al. Prevalência e fatores de risco associados à Leptospira spp. em rebanhos bovinos da região centro-sul do estado do Paraná. Embrapa Rondônia-Artigo em periódico indexado (ALICE). 2012 - 59.
Sonthayanon P, Chierakul W, Wuthiekanun V, Thaipadungpanit J, Kalambaheti T, Boonsilp S, et al. Accuracy of loop-mediated isothermal amplification for diagnosis of human leptospirosis in Thailand. The American Journal of Tropical Medicine and Hygiene. 2011; 84 (4):614-620 - 60.
Mori Y, Notomi T. Loop-mediated isothermal amplification (LAMP): A rapid, accurate, and cost-effective diagnostic method for infectious diseases. The Journal of Infusional Chemotherapy. 2009; 15 (2):62-69 - 61.
Lin Y-P, Lee D-W, McDonough SP, Nicholson L, Sharma Y, Chang Y-F. The repeated domains of Leptospira immunoglobulin-like proteins interact with elastin and tropoealstin. Journal of Biological Chemistry. 2009;284 (29):19380-19391 - 62.
Alton GD, Berke O, Reid-Smith R, Ojkic D, Prescott JF. Increase in seroprevalence of canine leptospirosis and its risk factors, Ontario 1998-2006. Canadian Journal of Veterinary Research. 2009; 73 (3):167 - 63.
Winslow WE, Merry DJ, Pirc ML, Devine PL. Evaluation of a commercial enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody in diagnosis of human leptospiral infection. Journal of Clinical Microbiology. 1997; 35 (8):1938-1942 - 64.
Braunwald E, Fauci A, Kasper A. Harrison’s Principles of Internal Medicine. New York: McGrawHill; 2001 - 65.
Mcclain JBL, Ballou WR, Harrison SM, Steinweg DL. Doxycycline therapy for leptospirosis. Annals of Internal Medicine. 1984; 100 (5):696-698 - 66.
Daher EDF, Nogueira CB. Evaluation of penicillin therapy in patients with leptospirosis and acute renal failure. Revista do Instituto de Medicina Tropical de São Paulo. 2000; 42 (6):327-332 - 67.
Suputtamongkol Y, Niwattayakul K, Suttinont C, Losuwanaluk K, Limpaiboon R, Chierakul W, et al. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clinical Infectious Diseases. 2004; 39 (10):1417-1424 - 68.
Panaphut T, Domrongkitchaiporn S, Vibhagool A, Thinkamrop B, Susaengrat W. Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clinical Infectious Diseases. 2003; 36 (12):1507-1513 - 69.
Niwattayakul K, Kaewtasi S, Chueasuwanchai S, Hoontrakul S, Chareonwat S, Suttinont C, et al. An open randomized controlled trial of desmopressin and pulse dexamethasone as adjunct therapy in patients with pulmonary involvement associated with severe leptospirosis. Clinical Microbiology and Infection. 2010; 16 (8):1207-1212 - 70.
Karande S, Satam N, Kulkarni M, Bharadwaj R, Pol S. Leptospiral pneumonia. Indian Journal of Pediatrics. 2005; 72 (1):86 - 71.
Ozkanlar Y, Aktas M, Kaynar O, Ozkanlar S, Celebi F. Efficacy of blood transfusion accompanied by antibiotics and B vitamins for the treatment of naturally occurring leptospirosis in cattle. Revista de Medicina Veterinaria. 2010; 161 (7):336-341 - 72.
Thompson JC, Manktelow B. Pathogenesis and red blood cell destruction in haemoglobinaemic leptospirosis. Journal of Comparative Pathology. 1986; 96 (5):529-540 - 73.
Goarant C. Leptospirosis: Risk factors and management challenges in developing countries. Research and Reports in Tropical Medicine. 2016; 2016 (7):29-62 - 74.
Hunt E, Wood B. Use of blood and blood products. Veterinary Clinics: Food Animal Practice. 1999; 15 (3):641-662 - 75.
Conference PottWDM. Western Dairy Management Conference; 2003